论文部分内容阅读
目的:探讨奥曲肽运用在肠梗阻治疗中的临床价值。方法:选取2012年5至2015年5月该院收治的肠梗阻非手术患者32例,按随机数字表法分为对照组(16例)和观察组(16例),对照组接受常规治疗,观察组在常规治疗基础上加用奥曲肽。比较两组临床症状缓解时间(腹痛、腹胀、恶心)、肛门排气、排便时间、胃肠减压量、住院时间及临床疗效。结果:观察组腹痛缓解时间、腹胀缓解时间,恶心缓解时间,肛门排气时间、排便时间,住院时间,均明显短于对照组(P<0.05),胃肠减压量明显少于对照组(P<0.05)。观察组治疗总有效率为87.50%,明显高于对照组的68.75%(P<0.05)。结论:奥曲肽用于肠梗阻非手术治疗,可明显缓解患者的临床症状和体征,疗效显著,值得推广。
Objective: To investigate the clinical value of octreotide in the treatment of intestinal obstruction. Methods: Thirty-two patients with intestinal obstruction who were treated in our hospital from May 2012 to May 2015 were divided into control group (n = 16) and observation group (n = 16) according to random number table. The control group received routine treatment, The observation group added octreotide on the basis of routine treatment. The clinical symptom relief time (abdominal pain, abdominal distension, nausea), anal exhaust, defecation time, gastrointestinal decompression, hospital stay and clinical curative effect were compared between the two groups. Results: The pain relief time, abdominal distension time, nausea relief time, anal exhaust time, defecation time and hospital stay in the observation group were significantly shorter than those in the control group (P <0.05) P <0.05). The total effective rate in observation group was 87.50%, which was significantly higher than that in control group (68.75%, P <0.05). Conclusion: Octreotide is used in non-surgical treatment of intestinal obstruction, which can significantly relieve the clinical symptoms and signs of patients with significant curative effect and is worthy of promotion.